577 related articles for article (PubMed ID: 7580171)
21. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
't Jong GW; van den Anker JN
Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
[No Abstract] [Full Text] [Related]
22. ADHD, growth deficits, and relationships to psychostimulant use.
Joshi SV
Pediatr Rev; 2002 Feb; 23(2):67-8; discussion 67-8. PubMed ID: 11826259
[No Abstract] [Full Text] [Related]
23. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
Pelz R; Banaschewski T; Becker K
Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
[TBL] [Abstract][Full Text] [Related]
24. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
25. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
Varley CK
Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
[No Abstract] [Full Text] [Related]
26. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
[TBL] [Abstract][Full Text] [Related]
27. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
28. Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.
Rapoport JL; Inoff-Germain G
J Atten Disord; 2002; 6 Suppl 1():S57-60. PubMed ID: 12685519
[TBL] [Abstract][Full Text] [Related]
29. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
30. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.
Solanto MV
Behav Brain Res; 1998 Jul; 94(1):127-52. PubMed ID: 9708845
[TBL] [Abstract][Full Text] [Related]
31. Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt BE; Aabech HS; Sundet K
J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):130-9. PubMed ID: 24666268
[TBL] [Abstract][Full Text] [Related]
32. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder.
Efron D; Jarman FC; Barker MJ
J Paediatr Child Health; 1998 Jun; 34(3):288-92. PubMed ID: 9633980
[TBL] [Abstract][Full Text] [Related]
33. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
Nolan EE; Gadow KD; Sprafkin J
Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
[TBL] [Abstract][Full Text] [Related]
34. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
35. Methylphenidate: growth retardation.
Prescrire Int; 2011 Oct; 20(120):238-9. PubMed ID: 21970086
[TBL] [Abstract][Full Text] [Related]
36. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
37. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
38. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
Kollins SH; Shapiro SK; Newland MC; Abramowitz A
Exp Clin Psychopharmacol; 1998 Nov; 6(4):375-389. PubMed ID: 9861552
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence.
Gordon SM; Tulak F; Troncale J
J Addict Dis; 2004; 23(4):31-40. PubMed ID: 15339712
[TBL] [Abstract][Full Text] [Related]
40. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
